Oracle buys IP assets of firm linked to SAP
Conformia received a minority investment from SAP two years ago and has now agreed to sell its intellectual property assets to Oracle
Oracle has acquired the intellectual property assets of Conformia, a provider of pharmaceutical management software.
Conformia has ties to Oracle’s main-competitor, SAP. The German-based software company provided financial backing for Conformia in 2007 through its NetWeaver Fund, which operates a $125 million investment portfolio.
As part of the deal with Oracle, Conformia’s existing software will be incorporated into the Californian-based company’s Agile Product Lifecycle Management (PLM) solution.
"The addition of Conformia software technology underscores Oracle’s commitment to provide customers with a differentiated, out-of-box industry-based solution," said Hardeep Gulati , vice president of PLM strategy at Oracle. "Oracle’s PLM offering will give our Life Sciences industry customers a complete solution to manage drug design, development to commercialisation."
The agreement continues on from Oracle’s much larger acquisition of Sun Microsystems for in April, ending months of speculation that IBM intended to purchase the technology provider.